Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflibercept PK in Vitrectomized vs Non-vitrectomized DME Eyes
NCT04588948Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
A Phase 2 trial of aflibercept in diabetic macular edema (DME), sponsored by Stanford University. Planned start Dec 2020; status: withdrawn.
02
Drugs
aflibercept
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04588948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588948.